Smoking cessation and the cardiovascular specialist: Canadian cardiovascular society position paper

Canadian Journal of Cardiology

Volumn 27, Issue 2, 2011, Pages 132-137

  Pipe, Andrew L ^a   Eisenberg, Mark J ^b   Gupta, Anil ^c   Reid, Robert D ^a   Suskin, Neville G ^d   Stone, James A ^e  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Trillium Health Centre Missassauga   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; VARENICLINE;

ACUPUNCTURE; ARTICLE; CANADA; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HOSPITAL CARE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPNOSIS; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; NICOTINE REPLACEMENT THERAPY; OUTPATIENT CARE; SMOKING CESSATION; TOBACCO DEPENDENCE; CARDIOVASCULAR DISEASE; METHODOLOGY; MORBIDITY; REVIEW; RISK ASSESSMENT; SMOKING;

CANADA; CARDIOVASCULAR DISEASES; HUMANS; MORBIDITY; RISK ASSESSMENT; SMOKING; SMOKING CESSATION;

EID: 79957987208     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.060     Document Type: Article

References (61)

1. Canadian Tobacco Use Monitoring Survey. Canadian Tobacco Use Monitoring Survey. http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/researchrecherche/stat/ctums-esutc_2009/w-p-1_histo-eng.php. 2010. Accessed January 12, 2010.
2. CanadianTobaccoUseMonitoring Survey(CTUMS).Available at: http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/ctums-esutc_2009-eng.php. Accessed September 21, 2010.
3. Reid RD, Mullen KA, Slovinec D'Angelo ME, et al. Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model." Nicotine Tob Res Jan 2010;12:11-8.
4. Benowitz N. Nicotine addiction. NEJM 2010;362:2295-303.
5. Pipe AL, Papadakis S, Reid RD. The role of smoking cessation in the prevention of coronary artery disease. Curr Atheroscler Rep 2010;12:145-50.
6. Ambrose J, Barua R. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731-7.
7. Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 2009;205:23-32.
8. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
9. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Pevention and Health Promotion, Office on Smoking and Health, 2004.
10. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003;46:11-29.
11. Tonstad S, Andrew Johnston J. Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil 2006;13:507-14.
12. Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther 2004;42:83-92.
13. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997;96:3243-7.
14. Barth J, Critchley J, Bengel J. Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis. Ann Behav Med 2006;32:10-20.
15. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97.
16. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
17. Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. JACC 2001;37:1677-82.
18. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Dept of Health and Human Services, Public Health Service, 2008.
19. Reid RD, Pipe AL, Quinlan B. Promoting smoking cessation during hospitalization for coronary artery disease. Can J Cardiol 2006;22: 775-80.
20. Forrester JS, Merz CN, Bush TL, et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management. J Am Coll Cardiol 1996;27:991-1006.
21. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002;137:494-500.
22. Rigotti NA, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery: results of a randomized trial with 5-year follow-up. Ann Intern Med 1994;120:287-93.
23. Rigotti NA, Singer DE, Mulley AG Jr, Thibault GE. Smoking cessation following admission to a coronary care unit. J Gen Intern Med 1991;6: 305-11.
24. Cahill K, Stead L, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007;1:CD006103.
25. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, 2000.
26. Fiore MC, Jaen CR. A clinical blueprint to accelerate the elimination of tobacco use. JAMA 2008;299:2083-5.
27. Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;1:CD000031.
28. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005;2:CD001292.
29. Ranney L, Melvin C, Lux L, McClain E, Lohr KN. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med 2006;145:845-56.
30. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;3: CD000146.
31. WuP, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006;6:300.
32. Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008; 179:135-44.
33. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007;131:446-52.
34. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2007;3:CD001837.
35. Kahn R, Robertson JT, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008;118:576-85.
36. Frishman WH, Mitta W, Kupersmith A, Ky T. Nicotine and non-nicotine smoking cessation pharmacotherapies. Cardiol Rev 2006;14:57-73.
37. McEwen A, Hayek P, McRobbie H, West R. Manual of Smoking Cessation: A Guide for Counsellors and Practitioners. Oxford, UK: Blackwell, 2006.
38. The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel Liaisons and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A US Public Health Service Report. Am J Prevent Med 2008;35:158-76.
39. Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Prog Cardiovasc Dis 2003;45:429-41.
40. Hubbard R, Lewis S, Smith C, et al. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 2005;14:416-21.
41. Hoffman D, Hoffman I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997;50:307-64.
42. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-31.
43. Meine T, Patel M, Washam J, Pappas P, Jollis J. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005;95:976-8.
44. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation (review). Cochrane Database Syst Rev 2008;1: CD000146.
45. Catley D, Harris KJ, Okuyemi KS, Mayo MS, Pankey E, Ahluwalia JS. The influence of depressive symptoms on smoking cessation on African Americans in a randomized trial of bupropion. Nicotine TobRes 2005;7:859-70.
46. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J 2003;24:946-55.
47. Rigotti NA, Thorndike AN, Regan S, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 2006;119:1080-7.
48. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 2010;121:221-9.
49. Vidrine JI, Cofta-Woerpel L, Daza P, Wright KL, Wetter DW. Smoking cessation 2: behavioral treatments. Behav Med 2006;32:99-109.
50. Wolfenden L, Campbell E, Walsh R, Wiggers J. Smoking cessation interventions for in-patients: a selective review with recommendations for hospital-based health professionals. Drug Alcohol Rev 2003;22:437-52.
51. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2006;1: CD000009.
52. Abbot NC, Stead LF, White AR, Barnes J, Ernst E. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2000;2:CD001008.
53. Wu TP, Chen FP, Liu JY, Lin MH, Hwang SJ. A randomized controlled clinical trial of auricular acupuncture in smoking cessation. J Chin Med Assoc 2007;70:331-8.
54. Balady GJ, Williams MA, Ades PA, et al. AHA/AACVPR Scientific Statement. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update. J Cardiopulm Rehabil Prev 2007;27:121-9.
55. Suskin N, Pipe A, Prior P. Smokers paradox or not in heart failure. Just quit. Eur Heart J 2008;29:1932-3.
56. Milionis HJ, Rizos E, Mikhailidis DP. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology 2001; 52:575-87.
57. Journath G, Nilsson PM, Petersson U, Paradis BA, Theobald H, Erhardt L. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment: a national study in Sweden. Blood Pressure 2005;14:144-50.
58. Frey P, Waters DD, DeMicco DA, et al. Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] Trials). Am J Cardiol 2011;107:145-50.
59. Curry SJ, Orleans CT, Keller P, Fiore M. Promoting smoking cessation in the healthcare environment: 10 years later. Am J Prev Med 2006;31:269-72.
60. Orleans CT, Woolf SH, Rothemich SF, Marks JS, Isham GJ. The top priority: building a better system for tobacco-cessation counseling. Am J Prev Med 2006;31:103-6.
61. Reid RD, Mullen KA, Slovinec D'Angelo ME, et al. Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model." Nicotine Tob Res 2010;12:11-8.